Clinical trial

Docetaxel and Cyclophosphamide Compared to Anthracycline-Based Chemotherapy in Treating Women With HER2-Negative Breast Cancer

NCT01547741

Study summary

ClinicalTrials.gov

Docetaxel and Cyclophosphamide Compared to Anthracycline-Based Chemotherapy in Treating Women With HER2-Negative Breast Cancer

Design: INTERVENTIONAL · Status: COMPLETED · Phase: PHASE3

Loading study purpose, treatment groups and outcomes…

View the complete registry record, eligibility and contacts at ClinicalTrials.gov

Drugs and interventions used in this trial

4 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

DRUG · Mapped RxNorm record Doxorubicin Normalized identity: doxorubicin View linked drug · Find medicine records · Find other trials using this name

DRUG · Mapped RxNorm record Cyclophosphamide Normalized identity: cyclophosphamide View linked drug · Find medicine records · Find other trials using this name

DRUG · Mapped RxNorm record Docetaxel Normalized identity: docetaxel View linked drug · Find medicine records · Find other trials using this name

DRUG · Mapped RxNorm record Paclitaxel Normalized identity: paclitaxel View linked drug · Find medicine records · Find other trials using this name

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2012-04-01

PhasePHASE3

Conditions

Breast Cancerverified · MONDO: breast cancer

Interventions

DoxorubicinDRUG · verified · RxNorm: doxorubicin

CyclophosphamideDRUG · verified · RxNorm: cyclophosphamide

DocetaxelDRUG · verified · RxNorm: docetaxel

PaclitaxelDRUG · verified · RxNorm: paclitaxel

Sponsors & collaborators

NSABP Foundation Inclead sponsor

National Cancer Institute (NCI)collaborator

Mapped research locations

HonoluluHawaii, United States9 Kansas CityMissouri, United States8 OaklandCalifornia, United States8 St LouisMissouri, United States7 SeattleWashington, United States7 ColumbusOhio, United States7 DenverColorado, United States7 BaltimoreMaryland, United States6 OmahaNebraska, United States6 ToledoOhio, United States6 Des MoinesIowa, United States6 Green BayWisconsin, United States6

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT01547741 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.